I run a small software development company and we’ve had experience of developing mobile apps for clients that are classed as medical devices, so they carry the CE mark. All our experience to date has been on developing class 1 safety class A devices for Europe so we have complied with the EU MDD . We’re not certified to 13485 but our software development processes are aligned to harmonised standards like IEC 62304 and we have always produced the Technical File for such projects which has been handed over to the client so that they can register the device with the MHRA in the UK. We have an opportunity to develop some software which under the new MDR will be classified as a IIa device but we are not sure if the Technical File structure/content areas that we’ve used for developing class I devices would be sufficient and meet the compliance requirements for developing class IIa device software? We also want to transition to the new MDR and we’re currently unsure how to approach this and was wondering what practical steps we could take to begin the process. Any help and advice from someone more expert on all this than myself would be much appreciated.
Hi,
The advice you received here isn't wrong for the most part, but it ignores the fact that you are not the brand owner (the legal Manufacturer). If I understood correctly, you are a supplier / a service provider (the service = product / software development) to a medical devices Manufacturer. This is true regardless of whether they actually "manufacture" or not. As such, most of the statements made above are applicable to your client, not directly to you. You may, of course, take on some of their tasks under contract (but they remain responsible, in regulatory terms).
With specific regard to Technical Documentation, BSI issued some worthy guidance (they call it a white paper) on the subject, under the MDR, so I'd have a look at that first. It's available from their website for free (no affiliation here). BTW, BSI is currently the only NB already designated under the MDR, but they are designated in the UK, by the MHRA, so not sure what's going to happen with that upon Brexit. Their NL branch is currently only designated under the MDD.
More generally, if you want to fully understand the obligations under the MDR, or the changes from the MDD, I strongly suggest reading the MDR itself. Contrary to common belief, it is accessible to intelligent beings... if you are really after a good understanding I wouldn't go to specific Annexes etc., but rather start from page 1 and read through. You can skip clearly irrelevant parts though, e.g. Articles relating to NB designation etc.
Good luck,
Ronen.